Do analysts recommend MTEX or BHST?

BioHarvest Sciences has a consensus target price of $6.50, suggesting a potential upside of 261.11%. Given BioHarvest Sciences' stronger consensus rating and higher possible upside, analysts clearly believe BioHarvest Sciences is more favorable than Mannatech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mannatech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BioHarvest Sciences 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media favor MTEX or BHST?

In the previous week, BioHarvest Sciences had 1 more articles in the media than Mannatech. MarketBeat recorded 3 mentions for BioHarvest Sciences and 2 mentions for Mannatech. Mannatech's average media sentiment score of 0.00 equaled BioHarvest Sciences'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mannatech 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BioHarvest Sciences 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend MTEX or DSY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mannatech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Big Tree Cloud 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, MTEX or DSY?

Mannatech has higher revenue and earnings than Big Tree Cloud. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mannatech $108.04M 0.13 -$15.21M -$3.91 N/A Big Tree Cloud $2.56M 7.25 -$32.53M N/A N/A

Does the media prefer MTEX or DSY?

In the previous week, Mannatech had 1 more articles in the media than Big Tree Cloud. MarketBeat recorded 2 mentions for Mannatech and 1 mentions for Big Tree Cloud. Big Tree Cloud's average media sentiment score of 0.80 beat Mannatech's score of 0.00 indicating that Big Tree Cloud is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mannatech 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Big Tree Cloud 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer MTEX or NHTC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mannatech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Natural Health Trends 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor MTEX or NHTC?

In the previous week, Mannatech had 1 more articles in the media than Natural Health Trends. MarketBeat recorded 2 mentions for Mannatech and 1 mentions for Natural Health Trends. Natural Health Trends' average media sentiment score of 1.08 beat Mannatech's score of 0.00 indicating that Natural Health Trends is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mannatech 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Natural Health Trends 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend NAII or MTEX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Mannatech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer DRMA or MTEX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dermata Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Mannatech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Mannatech (MTEX) Competitors

$7.29 +0.47 (+6.89%)

As of 09/3/2026 04:00 PM Eastern

Compare

MTEX vs. BHST, DSY, NHTC, NAII, and DRMA

Should you buy Mannatech stock or one of its competitors? Mannatech's main competitors and comparable companies include BioHarvest Sciences (BHST), Big Tree Cloud (DSY), Natural Health Trends (NHTC), Natural Alternatives International (NAII), and Dermata Therapeutics (DRMA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Mannatech compare to BioHarvest Sciences?

Mannatech (NASDAQ:MTEX) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

BioHarvest Sciences has a consensus target price of $6.50, suggesting a potential upside of 261.11%. Given BioHarvest Sciences' stronger consensus rating and higher possible upside, analysts clearly believe BioHarvest Sciences is more favorable than Mannatech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mannatech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BioHarvest Sciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Mannatech has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market. Comparatively, BioHarvest Sciences has a beta of 0.94, indicating that its stock price is 6% less volatile than the broader market.

13.0% of Mannatech shares are held by institutional investors. 47.5% of Mannatech shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Mannatech has a net margin of -6.90% compared to BioHarvest Sciences' net margin of -31.21%. BioHarvest Sciences' return on equity of -58.30% beat Mannatech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mannatech	-6.90%	-2,383.34%	-24.43%
BioHarvest Sciences	-31.21%	-58.30%	-25.60%

BioHarvest Sciences has lower revenue, but higher earnings than Mannatech. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Mannatech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mannatech	$108.04M	0.13	-$15.21M	-$3.91	N/A
BioHarvest Sciences	$34.51M	1.02	-$11.14M	-$0.52	N/A

In the previous week, BioHarvest Sciences had 1 more articles in the media than Mannatech. MarketBeat recorded 3 mentions for BioHarvest Sciences and 2 mentions for Mannatech. Mannatech's average media sentiment score of 0.00 equaled BioHarvest Sciences'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mannatech	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
BioHarvest Sciences	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

BioHarvest Sciences beats Mannatech on 9 of the 15 factors compared between the two stocks.

How does Mannatech compare to Big Tree Cloud?

Mannatech (NASDAQ:MTEX) and Big Tree Cloud (NASDAQ:DSY) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

13.0% of Mannatech shares are owned by institutional investors. Comparatively, 60.2% of Big Tree Cloud shares are owned by institutional investors. 47.5% of Mannatech shares are owned by insiders. Comparatively, 34.1% of Big Tree Cloud shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mannatech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Big Tree Cloud	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Mannatech has higher revenue and earnings than Big Tree Cloud.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mannatech	$108.04M	0.13	-$15.21M	-$3.91	N/A
Big Tree Cloud	$2.56M	7.25	-$32.53M	N/A	N/A

Big Tree Cloud has a net margin of 0.00% compared to Mannatech's net margin of -6.90%. Big Tree Cloud's return on equity of 0.00% beat Mannatech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mannatech	-6.90%	-2,383.34%	-24.43%
Big Tree Cloud	N/A	N/A	N/A

In the previous week, Mannatech had 1 more articles in the media than Big Tree Cloud. MarketBeat recorded 2 mentions for Mannatech and 1 mentions for Big Tree Cloud. Big Tree Cloud's average media sentiment score of 0.80 beat Mannatech's score of 0.00 indicating that Big Tree Cloud is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mannatech	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Big Tree Cloud	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mannatech has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market. Comparatively, Big Tree Cloud has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

Summary

Big Tree Cloud beats Mannatech on 6 of the 11 factors compared between the two stocks.

How does Mannatech compare to Natural Health Trends?

Mannatech (NASDAQ:MTEX) and Natural Health Trends (NASDAQ:NHTC) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

Mannatech has a beta of 0.75, indicating that its share price is 25% less volatile than the broader market. Comparatively, Natural Health Trends has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market.

13.0% of Mannatech shares are held by institutional investors. Comparatively, 10.1% of Natural Health Trends shares are held by institutional investors. 47.5% of Mannatech shares are held by insiders. Comparatively, 12.9% of Natural Health Trends shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Natural Health Trends has lower revenue, but higher earnings than Mannatech. Natural Health Trends is trading at a lower price-to-earnings ratio than Mannatech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mannatech	$108.04M	0.13	-$15.21M	-$3.91	N/A
Natural Health Trends	$39.78M	0.35	-$880K	-$0.16	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mannatech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Natural Health Trends	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Natural Health Trends has a net margin of -4.51% compared to Mannatech's net margin of -6.90%. Natural Health Trends' return on equity of -8.00% beat Mannatech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mannatech	-6.90%	-2,383.34%	-24.43%
Natural Health Trends	-4.51%	-8.00%	-4.58%

In the previous week, Mannatech had 1 more articles in the media than Natural Health Trends. MarketBeat recorded 2 mentions for Mannatech and 1 mentions for Natural Health Trends. Natural Health Trends' average media sentiment score of 1.08 beat Mannatech's score of 0.00 indicating that Natural Health Trends is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mannatech	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Natural Health Trends	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Natural Health Trends beats Mannatech on 8 of the 13 factors compared between the two stocks.

How does Mannatech compare to Natural Alternatives International?

Natural Alternatives International (NASDAQ:NAII) and Mannatech (NASDAQ:MTEX) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

Natural Alternatives International has a beta of 0.36, suggesting that its stock price is 64% less volatile than the broader market. Comparatively, Mannatech has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market.

Natural Alternatives International has higher revenue and earnings than Mannatech. Mannatech is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natural Alternatives International	$129.86M	0.10	-$13.57M	-$2.39	N/A
Mannatech	$108.04M	0.13	-$15.21M	-$3.91	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natural Alternatives International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Mannatech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Mannatech had 2 more articles in the media than Natural Alternatives International. MarketBeat recorded 2 mentions for Mannatech and 0 mentions for Natural Alternatives International. Natural Alternatives International's average media sentiment score of 0.00 equaled Mannatech'saverage media sentiment score.

Company	Overall Sentiment
Natural Alternatives International	Neutral
Mannatech	Neutral

Mannatech has a net margin of -6.90% compared to Natural Alternatives International's net margin of -10.13%. Natural Alternatives International's return on equity of -12.21% beat Mannatech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natural Alternatives International	-10.13%	-12.21%	-5.30%
Mannatech	-6.90%	-2,383.34%	-24.43%

32.4% of Natural Alternatives International shares are owned by institutional investors. Comparatively, 13.0% of Mannatech shares are owned by institutional investors. 20.8% of Natural Alternatives International shares are owned by company insiders. Comparatively, 47.5% of Mannatech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Natural Alternatives International beats Mannatech on 7 of the 12 factors compared between the two stocks.

How does Mannatech compare to Dermata Therapeutics?

Dermata Therapeutics (NASDAQ:DRMA) and Mannatech (NASDAQ:MTEX) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, media sentiment, profitability, analyst recommendations, institutional ownership and valuation.

Dermata Therapeutics has a net margin of 0.00% compared to Mannatech's net margin of -6.90%. Dermata Therapeutics' return on equity of -166.66% beat Mannatech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dermata Therapeutics	N/A	-166.66%	-130.13%
Mannatech	-6.90%	-2,383.34%	-24.43%

8.7% of Dermata Therapeutics shares are owned by institutional investors. Comparatively, 13.0% of Mannatech shares are owned by institutional investors. 21.9% of Dermata Therapeutics shares are owned by company insiders. Comparatively, 47.5% of Mannatech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Dermata Therapeutics has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market. Comparatively, Mannatech has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dermata Therapeutics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Mannatech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Dermata Therapeutics has higher earnings, but lower revenue than Mannatech. Mannatech is trading at a lower price-to-earnings ratio than Dermata Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dermata Therapeutics	N/A	N/A	-$7.56M	-$4.39	N/A
Mannatech	$108.04M	0.13	-$15.21M	-$3.91	N/A

In the previous week, Mannatech had 2 more articles in the media than Dermata Therapeutics. MarketBeat recorded 2 mentions for Mannatech and 0 mentions for Dermata Therapeutics. Dermata Therapeutics' average media sentiment score of 0.98 beat Mannatech's score of 0.00 indicating that Dermata Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
Dermata Therapeutics	Positive
Mannatech	Neutral

Summary

Mannatech beats Dermata Therapeutics on 7 of the 12 factors compared between the two stocks.

Get Mannatech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MTEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MTEX vs. The Competition

Export

Metric	Mannatech	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$13.16M	$23.61B	$15.88B	$12.73B
Dividend Yield	N/A	4.33%	3.20%	8.86%
P/E Ratio	-1.86	19.28	13.53	25.25
Price / Sales	0.13	13.16	262,949.17	97.64
Price / Cash	N/A	27.10	57.26	52.26
Price / Book	-2.83	2.92	4.59	6.14
Net Income	-$15.21M	$1.13B	$836.00M	$349.01M
7 Day Performance	8.16%	-1.48%	-0.95%	-0.31%
1 Month Performance	43.79%	-0.73%	-0.56%	0.64%
1 Year Performance	-21.36%	-18.73%	12.06%	14.83%

Mannatech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MTEX Mannatech	0.3129 of 5 stars	$7.29 +6.9%	N/A	-22.9%	$13.16M	$108.04M	N/A	250	Gap Up High Trading Volume
BHST BioHarvest Sciences	2.691 of 5 stars	$2.02 -1.5%	$6.50 +221.8%	-76.5%	$40.21M	$34.51M	N/A	N/A
DSY Big Tree Cloud	0.741 of 5 stars	$4.16 +1.7%	N/A	-80.6%	$19.43M	$2.56M	N/A	82
NHTC Natural Health Trends	1.142 of 5 stars	$1.76 +0.6%	N/A	-63.6%	$15.01M	$39.78M	N/A	140	News Coverage Positive News
NAII Natural Alternatives International	0.7181 of 5 stars	$2.17 +0.5%	N/A	-41.6%	$13.55M	$129.86M	N/A	290

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MTEX) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mannatech (MTEX) Competitors

MTEX vs. BHST, DSY, NHTC, NAII, and DRMA

How does Mannatech compare to BioHarvest Sciences?

Summary

How does Mannatech compare to Big Tree Cloud?

Summary

How does Mannatech compare to Natural Health Trends?

Summary

How does Mannatech compare to Natural Alternatives International?

Summary

How does Mannatech compare to Dermata Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTEX vs. The Competition

Mannatech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mannatech (MTEX) Competitors

MTEX vs. BHST, DSY, NHTC, NAII, and DRMA

How does Mannatech compare to BioHarvest Sciences?

Do analysts recommend MTEX or BHST?

Which has more volatility and risk, MTEX or BHST?

Do institutionals and insiders hold more shares of MTEX or BHST?

Is MTEX or BHST more profitable?

Which has preferable valuation & earnings, MTEX or BHST?

Does the media favor MTEX or BHST?

Summary

How does Mannatech compare to Big Tree Cloud?

Do insiders and institutionals hold more shares of MTEX or DSY?

Do analysts recommend MTEX or DSY?

Which has better earnings & valuation, MTEX or DSY?

Is MTEX or DSY more profitable?

Does the media prefer MTEX or DSY?

Which has more risk & volatility, MTEX or DSY?

Summary

How does Mannatech compare to Natural Health Trends?

Which has more volatility & risk, MTEX or NHTC?

Do institutionals & insiders believe in MTEX or NHTC?

Which has better earnings and valuation, MTEX or NHTC?

Do analysts prefer MTEX or NHTC?

Is MTEX or NHTC more profitable?

Does the media favor MTEX or NHTC?

Summary

How does Mannatech compare to Natural Alternatives International?

Which has more volatility & risk, NAII or MTEX?

Which has better valuation and earnings, NAII or MTEX?

Do analysts recommend NAII or MTEX?

Does the media favor NAII or MTEX?

Is NAII or MTEX more profitable?

Do insiders and institutionals hold more shares of NAII or MTEX?

Summary

How does Mannatech compare to Dermata Therapeutics?

Is DRMA or MTEX more profitable?

Do institutionals & insiders hold more shares of DRMA or MTEX?

Which has more volatility & risk, DRMA or MTEX?

Do analysts prefer DRMA or MTEX?

Which has stronger earnings and valuation, DRMA or MTEX?

Does the media refer more to DRMA or MTEX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTEX vs. The Competition

Mannatech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools